Overview

Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo

Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
0
Participant gender:
All
Summary
The goal of this clinical trial is to assess the efficacy and safety of a combination of aminobutyric acid, glutamic acid, calcium, thiamine, pyridoxine and cyanocobalamin as adjuvant therapy for vertigo comparatively to ginger under a double-blind randomized study design.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Fundação Educacional Serra dos Órgãos
Treatments:
gamma-Aminobutyric Acid
Hydroxocobalamin
Pyridoxine
Thiamine
Vitamin B 12
Criteria
Inclusion Criteria:

- clinical kinetosis

- female study subjects must agree in using contraceptives during study period

- dated informed consent read, understood and undersigned

Exclusion Criteria:

- hypersensitivity to the drugs of the study

- history of gallblader stones

- history of gastric mucosa inflammation

- arterial blood pressure >145/100 mmHg

- use of medication for kinetosis other than the study drugs